SIREN : 810472159
FREQUENCE MEDICALE is a French company founded 11 years ago, specialized in the sector Formation continue d'adultes. Based in NANTERRE (92000), this company of category PME shows in 2023 a revenue of 3.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 426 486 € | 3 880 113 € | 4 298 916 € | 1 333 733 € | 1 148 233 € | 920 588 € | 676 557 € | 1 187 167 € | 399 444 € |
| Net income | 4 246 € | 120 225 € | 193 328 € | 75 879 € | 20 966 € | 11 016 € | -321 128 € | -127 647 € | -458 € |
| EBITDA | 177 911 € | 242 699 € | 436 909 € | -498 513 € | 66 371 € | 68 217 € | -515 567 € | -41 428 € | -247 € |
| Net margin | 0.1% | 3.1% | 4.5% | 5.7% | 1.8% | 1.2% | -47.5% | -10.8% | -0.1% |
In 2023, FREQUENCE MEDICALE achieves revenue of 3.4 M€. Over the period 2015-2023, the company shows strong growth with a CAGR (compound annual growth rate) of +30.8%. Significant drop of -12% vs 2022. After deducting consumption (0 €), gross margin stands at 3.4 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 178 k€, representing 5.2% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 4 k€, i.e. 0.1% of revenue. This profit can be retained or distributed to shareholders.
3 426 486 €
3 426 486 €
177 911 €
71 619 €
4 246 €
5.2%
The debt ratio (= Financial debt / Equity x 100) stands at 339%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 13%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 56.0 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 1.3% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
339.135%
13.273%
1.267%
55.971
56.1%
In 2023, the debt ratio of FREQUENCE MEDICALE (339.13) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
In 2023, the financial autonomy of FREQUENCE MEDICALE (13.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2023, the repayment capacity of FREQUENCE MEDICALE (55.97) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 195.80. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 38.1x. Operating income very largely covers interest expenses: high safety margin.
195.804
38.099
In 2023, the liquidity ratio of FREQUENCE MEDICALE (195.80) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2023, the interest coverage of FREQUENCE MEDICALE (38.1x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 103 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 256 days. Excellent situation: suppliers finance 153 days of the operating cycle (retail model). Inventory turnover is 10 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 385 days of revenue, i.e. 3.7 M€ to permanently finance. Over 2015-2023, WCR increased by +438%, requiring additional financing.
3 665 620 €
103 j
256 j
10 j
385 j
Based on 134 transactions of similar company sales (all years), the value of FREQUENCE MEDICALE is estimated at 562 792 € (range 193 408€ - 1 233 507€). With an EBITDA of 177 911€, the sector multiple of 2.2x is applied. The price/revenue ratio is 0.36x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 134 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare FREQUENCE MEDICALE with other companies in the same sector:
Voir toutes les statistiques du secteur Formation continue d'adultes
The revenue of FREQUENCE MEDICALE in 2023 is 3.4 M€.
Yes, FREQUENCE MEDICALE generated a net profit of 4 k€ in 2023.
The headquarters of FREQUENCE MEDICALE is located in NANTERRE (92000), in the department Hauts-de-Seine.
The tax return of FREQUENCE MEDICALE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
FREQUENCE MEDICALE operates in the sector Formation continue d'adultes (NAF code 85.59A). See the 'Sector positioning' section above to compare the company with its competitors.